Top Thrombocytopenia Companies in South Korea | Leaders 2026

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA13273

Publication Date: Jul 2026

Top Thrombocytopenia Companies in South Korea

The following is a data-backed list of the leading South Korea Thrombocytopenia companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the South Korea Thrombocytopenia Industry, including Handok, Novartis Korea, and other established names.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full South Korea Thrombocytopenia Industry.

View Main Report Schedule Analyst Call

List of Thrombocytopenia companies in South Korea:

1. Handok

Company Name	Handok
Established Year	1954
Headquarters	Seoul, South Korea
Official Website	Click Here

Leads the local commercialization of innovative rare blood disorder therapies, including advanced treatments for chronic immune thrombocytopenia.

2. Novartis Korea

Company Name	Novartis Korea
Established Year	1986 (Group: 1996)
Headquarters	Basel, Switzerland (Local Hub: Seoul)
Official Website	Click Here

Provides targeted thrombopoietin receptor agonist solutions designed to manage low platelet counts in refractory immune thrombocytopenia patients.

3. Amgen Korea

Company Name	Amgen Korea
Established Year	1980 (Group: 2015 in Korea)
Headquarters	Thousand Oaks, USA (Local Hub: Seoul)
Official Website	Click Here

Offers specialized biotechnology medicines supporting clinical haematology protocols for severe platelet production and platelet-related disorders.

4. Pfizer Korea

Company Name	Pfizer Korea
Established Year	1959 (in Korea)
Headquarters	New York, USA (Local Hub: Seoul)
Official Website	Click Here

Supplies critical pharmaceutical lines and clinical support networks addressing complex haematological conditions and underlying coagulation complications.

5. Sanofi-Aventis Korea

Company Name	Sanofi-Aventis Korea
Established Year	1989 (in Korea)
Headquarters	Paris, France (Local Hub: Seoul)
Official Website	Click Here

Delivers essential specialty care medications utilized across hospital haematology departments for managing chronic immune-mediated blood profiles.

6. Kyowa Kirin Korea

Company Name	Kyowa Kirin Korea
Established Year	1949 (Group: 1990s in Korea)
Headquarters	Tokyo, Japan (Local Hub: Seoul)
Official Website	Click Here

Focuses on cutting-edge antibody and recombinant protein therapeutics targeting rare haematological disorders and bone marrow cell regulation.

7. Takeda Pharmaceutical Korea

Company Name	Takeda Pharmaceutical Korea
Established Year	1781 (Group: 1992 in Korea)
Headquarters	Tokyo, Japan (Local Hub: Seoul)
Official Website	Click Here

A major biopharmaceutical provider delivering advanced rare disease treatments and supportive care options for complex haematology patients.

8. Bayer Korea

Company Name	Bayer Korea
Established Year	1863 (Group: 1955 in Korea)
Headquarters	Leverkusen, Germany (Local Hub: Seoul)
Official Website	Click Here

Contributes specialized cardiovascular and haematology solutions that assist clinicians in monitoring bleeding risks and platelet management.

9. JW Pharmaceuticals

Company Name	JW Pharmaceuticals
Established Year	1945
Headquarters	Seoul, South Korea
Official Website	Click Here

Manufactures critical domestic hospital treatments and intravenous solutions supporting comprehensive therapeutic care across national medical centres.